Carlsmed, a spine medtech company, launched its initial public offering of 6.7 million shares of common stock, according to a June 15 news release.
Common stock price is expected to be between $14 and $16 per share, and the company applied to be listed on the Nasdaq Global Select Market.
Carlsmed is behind aprevo personalized spine implants. The company filed for the IPO in June, and BofA Securities, Goldman Sachs & Co. LLC and Piper Sandler are the joint lead book-running managers and representatives.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.